The University of Las Palmas de Gran Canaria, also known as the ULPGC is a Spanish university located in Las Palmas de Gran Canaria, the capital city of Gran Canaria island. It consists of five campuses: four in Gran Canaria and one in the island of Lanzarote, with Tafira being the largest. The University was created in 1989 after many years of petitions from the people of Gran Canaria. The university was incorporated through the University Reorganization Act of 1989. ULPGC was created as the aggregation of the teaching centers of former "Universidad Politécnica de Canarias", focused on engineering , and the centers from neighboring Universidad de La Laguna that were located in Las Palmas province. Wikipedia.
Agency: European Commission | Branch: H2020 | Program: RIA | Phase: INFRAIA-1-2014-2015 | Award Amount: 9.71M | Year: 2015
AQUAEXCEL2020 aims to integrate top class European aquaculture research facilities of very diverse nature, covering all relevant scientific fields for research and innovation in aquaculture, from genetics to technology through pathology, physiology and nutrition. It will put in place a user-friendly one-stop access to high-quality services and resources from 39 installations covering both established and new aquaculture species, all types of experimental systems as well as sequencing facilities. Giving a prominent place to EU aquaculture industry research needs through a strong involvement of the European Aquaculture Technology and Innovation Platform, it will enable excellent research and sustainable innovation to both public and private sector. It will benefit from the support of the ESFRI infrastructures EMBRC (Marine Biology) and ELIXIR (Life Sciences data) and bring aquaculture research specificities to their agendas. AQUAEXCEL2020 will be a key vehicle in the improvement of aquaculture research practices to the benefit of industry through finalized research and innovation, and of excellent science through the development of highly innovative methods and approaches such as Virtual Laboratories, standardized experimental fish lines and nano-sensors. It will also benefit to society through the development of methods for sustainable aquaculture, such as the use of cleaner fish to control parasites or Integrated Multitrophic Aquaculture, and also through a better management of animal experiments for research according to the 3 Rs, Reduction (via e.g. capitalization of data and provision of stable experimental fish lines), Refinement (via a better control of experimental procedures) and Replacement (via e.g. Virtual Laboratories). As a whole, AQUAEXCEL2020 will provide a world-class platform for all types of fish culture research, from biology to technology, in all types of rearing systems, with all major EU fish species, including the most promising new species.
Agency: European Commission | Branch: H2020 | Program: IA | Phase: MG-5.5a-2015 | Award Amount: 19.98M | Year: 2016
Within the EU, and particularly following the economic crisis; tourism will be, the engine for economic growth, particularly in the underperforming Mediterranean economies; where tourism has traditionally been a dominant economic sector. The world market of tourists continues to grow and Europe has unique selling points for further tourist growth from within and outside the EU (including China). The competitive market for tourism means that cities have to provide the high quality, sustainable environments desired by tourists, while providing local sustainable employment opportunities that overcome the seasonal and sometimes informal nature of tourist economies. Achieving sustainable mobility is a vital part of the growth equation for Europes tourist cities.DESTINATIONS will develop an innovative holistic approach to building sustainable urban mobility systems for both residents and tourists. The project impacts will make a positive contribution to demonstrating how this can achieve growth and therefore provide a benchmark for other EU tourist cities. DESTINATIONS will demonstrate and evaluate the effectiveness of innovative sustainable mobility solutions in 6 tourist cities with different characteristics but sharing common challenges. The solutions will address: Sustainable Urban Mobility Planning for residents and visitors Safe, attractive and accessible public spaces for all generations Shared mobility and e-infrastructures towards zero emissions transport Smart & clean urban freight logistics at tourist destinations Mobility management & awareness for sustainable mobility Attractive, clean, accessible and efficient public transport Achieving the objectives will increase the attractiveness of the city, both for tourists and for businesses in the sector and multiplier impacts in the economy for goods and services. All of these will contribute to better social cohesion (which attracts further investment). So sustainable mobility grows the economy.
Agency: European Commission | Branch: H2020 | Program: RIA | Phase: WASTE-6b-2015 | Award Amount: 4.25M | Year: 2016
Europes cities are some of the worlds greatest tourism destinations. The socio-economic impact of tourism is extraordinary and urban tourism, but it brings at the same time a range of negative externalities, including high levels of unsustainable resource consumption and waste production. In comparison with other cities, tourist cities have to face additional challenges related to waste prevention and management due to their geographical and climatic conditions, the seasonality of tourism flow and the specificity of tourism industry and of tourists as waste producers. UrBAN-WASTE will support policy makers in answering these challenges and in developing strategies that aim at reducing the amount of municipal waste production and at further support the re-use, recycle, collection and disposal of waste in tourist cities. In doing so UrBAN-WASTE will adopt and apply the urban metabolism approach to support the switch to a circular model where waste is considered as resource and reintegrated in the urban flow. UrBAN-WASTE will perform a metabolic analysis of the state of art of urban metabolism in 11 pilot cities. In parallel a participatory process involving all the relevant stakeholders will be set up through a mobilization and mutual learning action plan. These inputs will be integrated in the strategies along with a review of the most innovative existing technologies and practices in the field of waste management and prevention. The strategies will then be implemented in the 11 cities and the results will be monitored and disseminated facilitating the transfer and adaptation of the project outcomes in other cases.
Agency: European Commission | Branch: H2020 | Program: MSCA-RISE | Phase: MSCA-RISE-2016 | Award Amount: 828.00K | Year: 2017
Osteoarthritis (OA) is a degenerative joint disease, typified by a loss of quality of cartilage and changes in bone at the interface of a joint, resulting in pain, stiffness and reduced mobility. BAMOS project particularly addresses the challenges in OA treatment by providing novel cost effective osteochondral scaffold technology for early intervention of OA to delay or avoid the joint replacement operations. This project has the potential to relieve pain in patients with OA improving their quality of life by keeping people active. It fits with the scope of EU Societal Changellenges to encourage the provision of improved clinical care for patients in the field of healthcare, especially for elderly patients. In the course of developing this new treatment for mid- to late stage OA, BAMOS aims to establish and embed a new collaboration between six internationally leading research organisations (four universities, one healthcare provider and one manufacturer with expertise in additive manufacturing). The partners propose an integrated programme of research activities and the development of a collaborative graduate training scheme. The dissemination of research will result in at least 15 high profile joint research publications, and the consortium will organise two international scientific conferences (one in the EU, one in China) and 3 workshops. BAMOS will develop new materials and manufacturing technologies for the fabrication of custom-tailored osteochondral scaffolds. Novel biopolymeric composites, processed by additive manufacturing, will be characterized and tested as well as coatings on titanium scaffolds. Also, thermal welding technique will be used to join the cartilage component with the bone component to form an osteochondral unit. The new technologies will undergo full pre-clinical evaluation in order that the scaffolds are able to enter clinical trial after the project.
Agency: European Commission | Branch: H2020 | Program: IA | Phase: BG-01-2016 | Award Amount: 10.65M | Year: 2016
SABANA aims at developing a large-scale integrated microalgae-based biorefinery for the production of biostimulants, biopesticides and feed additives, in addition to biofertilizers and aquafeed, using only marine water and nutrients from wastewaters (sewage, centrate and pig manure). The objective is to achieve a zero-waste process at a demonstration scales up to 5 ha sustainable both environmentally and economically. A Demonstration Centre of this biorefinery will be operated to demonstrate the technology, assess the operating characteristics of the system, evaluate environment impacts and collaborate with potential customers for use. The key advantages of SABANA project are: the sustainability of the process, using marine water and recovering nutrients from wastewaters while minimizing the energy consumption, and the socioeconomic benefits, due to the relevance of the target bioproducts for two major pillars in food production as agriculture and aquaculture. Bioproducts capable of increasing the yield of crops and fish production are highly demanded, whereas recovery of nutrients is a priority issue in the EU. Instead of considering wastewater as an inevitably useless and problematic residue of our society, SABANA acknowledges its potential as an opportunity for economically relevant sectors. SABANA project includes (i) the utilization of microalgae-bacteria consortia and in co-culture with other algae to control grazing species, (ii) the implementation of efficient thin-layer cascade and raceway, (iii) the scale-up of reactors to ensure stable operation, (iv) to use marine water to increase the sustainability of the process; (v) to recover nutrients from wastewaters, (vi) to develop harvesting processes taking into account the remaining water, (vii) to establish processes for mild/energy efficient extraction of bioproducts, (viii) to process residual biomass to produce biofertilizers and aquafeed in zero-waste schemes, (ix) using robust and sustainable technology
Agency: European Commission | Branch: H2020 | Program: MSCA-RISE | Phase: MSCA-RISE-2016 | Award Amount: 1.60M | Year: 2017
The GHaNA project aims to explore and characterize a new marine bioresource, for blue biotechnology applications in aquaculture, cosmetics and possibly food and health industry. The project will determine the biological and chemical diversity of Haslea diatoms to develop mass-scale production for viable industrial applications by maximising biomass production and associated high-value compound production, including terpenoids, marennine-like pigments, lipids and silica skeletons. The genus Haslea species type H. ostrearia, produces marennine, a water-soluble blue pigment used for greening oysters in Western France, which is also a bioactive molecule. Haslea diatoms have thus a high potential for use in (1) existing oyster farming, (2) production of pigments and bioactive compounds with natural antibacterial properties, (3) application as a colouring agent within industry, and (4) use of silica skeletons as inorganic biocharges in the formulation of new elastomeric materials. This will be achieved through fundamental and applied-oriented research to isolate fast- growing strains of Haslea, optimising their growth environment to increase marennine and other high-value compound productivity; to develop blue biotechnology specifically applied to benthic microalgae (biorefinery approach, processes); and to develop industrial exploitation of colouring and bioactive compounds through commercial activities of aquaculture, food, cosmetics and health.
Agency: European Commission | Branch: H2020 | Program: ECSEL-IA | Phase: ECSEL-17-2015 | Award Amount: 64.82M | Year: 2016
ENABLE-S3 will pave the way for accelerated application of highly automated and autonomous systems in the mobility domains automotive, aerospace, rail and maritime as well as in the health care domain. Virtual testing, verification and coverage-oriented test selection methods will enable validation with reasonable efforts. The resulting validation framework will ensure Europeans Industry competitiveness in the global race of automated systems with an expected market potential of 60B in 2025. Project results will be used to propose standardized validation procedures for highly automated systems (ACPS). The technical objectives addressed are: 1. Provision of a test and validation framework that proves the functionality, safety and security of ACPS with at least 50% less test effort than required in classical testing. 2. Promotion of a new technique for testing of automated systems with physical sensor signal stimuli generators, which will be demonstrated for at least 3 physical stimuli generators. 3. Raising significantly the level of dependability of automated systems due to provision of a holistic test and validation platform and systematic coverage measures, which will reduce the probability of malfunction behavior of automated systems to 10E-9/h. 4. Provision of a validation environment for rapid re-qualification, which will allow reuse of validation scenarios in at least 3 development stages. 5. Establish open standards to speed up the adoption of the new validation tools and methods for ACPS. 6. Enabling safe, secure and functional ACPS across domains. 7. Creation of an eco-system for the validation and verification of automated systems in the European industry. ENABLE-S3 is strongly industry-driven. Realistic and relevant industrial use-cases from smart mobility and smart health will define the requirements to be addressed and assess the benefits of the technological progress.
Agency: European Commission | Branch: H2020 | Program: CSA | Phase: SC1-HCO-12-2016 | Award Amount: 1.97M | Year: 2016
Citizens digital health literacy is an essential element for successful eHealth deployment. However, citizens often do not have the necessary skills to find, understand and appraise online health information and apply their knowledge to make health decisions. Digitally health literate citizens are empowered to play a more active role in their health self-management, resulting in improved prevention, adherence to a healthier lifestyle and better health outcomes. IC-Health will provide support for the improvement of digital health literacy in Europe. In particular, the project will design 35 open access online courses (MOOCs), in seven different national languages, for different population cohorts including children, adolescents, pregnant and lactating women, elderly and people affected or susceptible to be affected by type 1 and type 2 diabetes. The identified population cohorts, along with health professionals, academics and other practitioners, will be organised in Communities of Practice and involved directly in the co-creation of the MOOCs content and structure. Once the courses are be designed, they will be tested by the members of the CoPs and by other users. MOOCs use and impact will be monitored and assessed in order to ensure their uptake and sustainability beyond the duration of the project.
Agency: European Commission | Branch: H2020 | Program: RIA | Phase: SFS-01b-2014 | Award Amount: 9.31M | Year: 2015
Helminth and ectoparasitic infections of ruminants and poultry have a huge impact on the biological efficiency of these vital food sources. Indiscriminate antiparasitic use has led to drug resistance across the globe. The main alternative to the dwindling supply of antiparasitics is vaccines. Here, in the PARAGONE project, findings from previous EU and other-funded projects on parasite vaccine development will be exploited to take a number of promising prototypes towards commercialisation. Partners from the Europe, China, Uruguay, SMEs and pharma, will directly move forward prototypes against the ruminant helminths Fasciola hepatica, Cooperia spp., Ostertagia ostertagi, Teladorsagia circumcincta and Haemonchus contortus and, the ectoparasitic mites, Psoroptes ovis (ruminants) and Dermanyssus gallinae (poultry). They will utilise novel adjuvants or delivery systems to maximise efficacy of some of the prototypes. Moreover, immunology studies will focus on pathogens that have previously proved problematic, often because they release immunosuppressive molecules that must be overcome for vaccines to work or because recombinant vaccines have failed to elicit protection observed with native prototypes. State-of-the-art technologies will be used to interrogate host/parasite interactions to define key signatures of protection that can be used to inform delivery systems that will enhance immunity, while other studies will define polymorphism in current vaccine candidates to ensure derived prototypes will be fit-for-purpose across geographic scales. Fundamental, is engagement of the scientists with pharma and other stakeholders (farmers, veterinarians, regulators) via many dissemination activities that will be used to obtain feedback on how the vaccines can be best deployed in the field. The output will be at least two prototypes to the point of uptake by pharma, government or philanthropic agencies, and a clear pathway to commercialisation for all prototypes studied.